Advanced search
Publication Cover
International Journal of Nanomedicine Volume 14, 2019 - Issue
Submit an article Journal homepage
114
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Superparamagnetic iron oxide nanoparticle-mediated expression of miR-326 inhibits human endometrial carcinoma stem cell growth

Yongtao Gao1 The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200030, People’s Republic of ChinaCorrespondence[email protected]
,
Haiyang Qian2 Department of Imaging, Dahua Hospital, Shanghai, 200237, People’s Republic of China
,
Xue Tang1 The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200030, People’s Republic of China
,
Xiling Du3 School of Life Science and Technology, Tongji University, Shanghai200092, People’s Republic of China
,
Gang Wang2 Department of Imaging, Dahua Hospital, Shanghai, 200237, People’s Republic of China
,
Hairong Zhang2 Department of Imaging, Dahua Hospital, Shanghai, 200237, People’s Republic of China
,
Fei Ye2 Department of Imaging, Dahua Hospital, Shanghai, 200237, People’s Republic of China
&
Te Liu4 Shanghai Geriatric Institute of Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai200031, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 2719-2731 | Published online: 18 Apr 2019

References

  • Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E. Endometrial cancer. Lancet. 2016;387(10023):1094–1108. doi:10.1016/S0140-6736(15)00130-026354523
  • Gao Y, Liu T, Huang Y. MicroRNA-134 suppresses endometrial cancer stem cells by targeting POGLUT1 and Notch pathway proteins. FEBS letters. 2015;589(2):207–214. doi:10.1016/j.febslet.2014.12.00225528443
  • Gao Y, Liu T, Cheng W, Wang H. Isolation and characterization of proliferative, migratory and multidrug-resistant endometrial carcinoma-initiating cells from human type II endometrial carcinoma cell lines. Oncol Rep. 2012;28(2):527–532. doi:10.3892/or.2012.180722581025
  • Dowdy SC, Glaser GE. Adjuvant therapy for women with high-risk endometrial carcinoma. Lancet Oncol. 2018;19(3):268–269. doi:10.1016/S1470-2045(18)30091-329449190
  • Kong YW, Ferland-McCollough D, Jackson TJ, Bushell M. microRNAs in cancer management. Lancet Oncol. 2012;13(6):e249–e258. doi:10.1016/S1470-2045(12)70073-622652233
  • Pan Z, Shi Z, Wei H, et al. Magnetofection based on superparamagnetic iron oxide nanoparticles weakens glioma stem cell proliferation and invasion by mediating high expression of microRNA-374a. J Cancer. 2016;7(11):1487–1496. doi:10.7150/jca.1551527471565
  • Liu T, Zhang H, Zheng J, et al. SPION-mediated miR-141 promotes the differentiation of HuAESCs into dopaminergic neuron-like cells via suppressing lncRNA-HOTAIR. J Cell Mol Med. 2018;22(4):2299–2310. doi:10.1111/jcmm.1351229411538
  • Fang K, Liu P, Dong S, et al. Magnetofection based on superparamagnetic iron oxide nanoparticle-mediated low lncRNA HOTAIR expression decreases the proliferation and invasion of glioma stem cells. Int J Oncol. 2016;49(2):509–518. doi:10.3892/ijo.2016.357127277755
  • Zhang H, Zheng J, Lin J, et al. miR-758 mediates oxLDL-dependent vascular endothelial cell damage by suppressing the succinate receptor SUCNR1. Gene. 2018;663:1–8. doi:10.1016/j.gene.2018.04.02929660520
  • Cheng W, Liu T, Wan X, Gao Y, Wang H. MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells. FEBS J. 2012;279(11):2047–2059. doi:10.1111/j.1742-4658.2012.08589.x22498306
  • Vargas SL, Toma I, Kang JJ, Meer EJ, Peti-Peterdi J. Activation of the succinate receptor GPR91 in macula densa cells causes renin release. J Am Soc Nephrol. 2009;20(5):1002–1011. doi:10.1681/ASN.200807074019389848
  • Mu X, Zhao T, Xu C, et al. Oncometabolite succinate promotes angiogenesis by upregulating VEGF expression through GPR91-mediated STAT3 and ERK activation. Oncotarget. 2017;8(8):13174–13185. doi:10.18632/oncotarget.1448528061458
  • Littlewood-Evans A, Sarret S, Apfel V, et al. GPR91 senses extracellular succinate released from inflammatory macrophages and exacerbates rheumatoid arthritis. J Exp Med. 2016;213(9):1655–1662. doi:10.1084/jem.2016006127481132
  • He W, Miao FJ, Lin DC, et al. Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature. 2004;429(6988):188–193. doi:10.1038/nature0248815141213
  • Favret S, Binet F, Lapalme E, et al. Deficiency in the metabolite receptor SUCNR1 (GPR91) leads to outer retinal lesions. Aging (Albany NY). 2013;5(6):427–444. doi:10.18632/aging.10056323833031
  • de Castro Fonseca M, Aguiar CJ, Da Rocha Franco JA, Gingold RN, Leite MF. GPR91: expanding the frontiers of Krebs cycle intermediates. Cell Commun Signal. 2016;14:3. doi:10.1186/s12964-016-0126-126759054
  • Aguiar CJ, Rocha-Franco JA, Sousa PA, et al. Succinate causes pathological cardiomyocyte hypertrophy through GPR91 activation. Cell Commun Signal. 2014;12:78. doi:10.1186/1478-811X-12-225539979
  • Tannahill GM, Curtis AM, Adamik J, et al. Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha. Nature. 2013;496(7444):238–242. doi:10.1038/nature1198623535595
  • Mills E, O‘Neill LA. Succinate: a metabolic signal in inflammation. Trends Cell Biol. 2014;24(5):313–320. doi:10.1016/j.tcb.2013.11.00824361092

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.